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www.sciencedirect.comCataract surgery has become a commonplace event with
an anticipated rapid improvement in visual function without
significant risk; 98% of the surgeries are considered to be
successes. Patients often ask ‘‘how long will the implant last,
doctor?’’ The response is usually, ‘‘we expect it to last your
lifetime, we are so confident in this that we even implant
them in children’’. Although this response is said with all sin-
cerity, is it really the case?
Initial IOLs were plagued by complications, in particular
uveitis, glaucoma and hyphema. However, since the 1980’s,
with improved manufacturing and processing of materials,
IOLs have been considered to be safe, and the standard of
care in cataract surgery. Surgeons routinely implant IOLs in
complicated cataract cases and patients with concurrent ocu-
lar disease, in spite of IOL package inserts which state that
IOL implantation in these cases is contraindicated. Experi-
ence has trumped caution as outcomes have been positive.
However, reports of IOL related complications continue to
remind ophthalmologists to be vigilant.
In the 1990’s, delayed opacification of hydrophilic IOLs
due were reported in 36% of some lens designs; granular
deposits were found on the surface of the optics on Hydro-
view (B&L) and Memory (Ciba Vision) lenses, and within the
substance of the optic in Aquasense (Ophthalmic Innovations
International Inc) and SC60B-OUV (Medical Development
Research) lenses. Silicone contaminants and phosphate buf-
fers were identified as being causative; IOLs were recalled
and manufacturing processes were altered.
More recently, attention has been drawn to opacification
of hydrophilic IOLs in intraocular cases which involve the
use of intracameral gas such as lamellar corneal surgery or
retinal procedures. Avoidance of this material in these cases
has been recommended.1
In the presence of asteroid hyalosis, silicone IOLs have
been reported to undergo calcific opacification.2
A voluntary recall of opacified Hydrosmart foldable lenses
(Lentis) stored in glass vials was announced in late 2014. Stor-
age of these lenses in blister packs has resulted in resolution
of the problem.
Recently, late onset ocular inflammation due to toxicity
from aluminum has been identified with the Hoya Isert 251
and 255 models.3
However, opacification of the IOL optic in Alcon
Acrysof lenses continues to be an issue since the 1990’s.
Glistening and subsurface nanoglistenings (SSNGs) (fluid
filled gaps in the optic of the IOL) are found in virtually100% of patients at 2–3 years post-operatively. Studies
have found that the density of the glistenings and the
consequent retinal straylight continue to increase
10–15 years post-operatively.4
The impact of glistenings and SSNGs on visual function is
highly contested. Many studies show that visual acuity, con-
trast sensitivity and MTF’s are not affected. Other studies
come to the conclusion that visual function is negatively
impacted. Although the conclusions may seem to be contra-
dictory, they are not because findings depend on testing con-
ditions. The inclusions in Acrysof lenses cause light scatter
and disability glare. If a light source strikes the lens slightly
off axis, light scatter occurs and visual function deteriorates.
Visual acuity, contrast sensitivity and MTF measurements
are made on axis and are minimally impacted. Repeating
measurements slightly off axis will result in a significant
decrease.
Explantation of glistening affected lenses and allowing
them to air dry results in a resolution of the glistenings. If
optical measurements are then performed on these lenses,
no effect will be found.
Light transmission studies using an integrated sphere
spectrophotometer will not find any difference between glis-
tening affected lenses and glistening free lenses since all light
is measured. A double beam spectrophotometer is a more
appropriate instrument for measuring the effect of light
scatter.
Disability glare has been implicated in the alteration of
driving habit and the causation of motor vehicle accidents.5
Ophthalmologists are familiar with and test for glare preop-
eratively in cataract patients in order to justify the interven-
tion. Glistenings and SSNGs cause disability glare; so it
should not be a complete surprise that they may impact on
driving. A Swedish study found that 43% of patients with
Acrysof lenses experienced night time glare at 6 years post-
operatively, which influenced their driving abilities.6 A recent
study has determined that at 3 years post-op, Acrysof lenses
may be associated with an increased incidence of self
reported motor vehicle accidents.7 With over 70 million Acr-
sof lenses implanted worldwide, it should be of some con-
cern that disability glare and loss of driving may reach
epidemic proportions.
Patients with Alcon Acrysof lenses complain of visual dis-
turbances, glare and poor vision in spite of having good Snel-
len acuity. IOL exchange for a glistening free lens has
resulted in a resolution of the symptoms.e:
al.com
248 EditorialHoya iSymm lenses were similarly affected by glistenings.
Hoya has removed this lens from the market and has
improved its manufacturing process. Alcon continues to pro-
duce its Acrysof material by a molding process which is prone
to glistening formation. Recent claims have been made that
glistenings have been addressed by current manufacturing
processes; however, reports have been published that the
new lenses continue to have significant glistenings.8
Given the possibility of impaired visual function due to
glistenings and SSNGs, one has to question the implantation
of Alcon Acrysof lenses in paediatric and young adults.
If a patient asks whether his intraocular lens will last a life-
time, the answer must be that it depends on his ocular health
and choice of intraocular lens.
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